Literature DB >> 19797668

Clinical relevance of autonomic nervous system disturbances in pulmonary arterial hypertension.

R Naeije, P van de Borne.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19797668     DOI： 10.1183/09031936.00091609

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  10 in total

1.  Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure.

Authors:  Paul R Woods; Kent R Bailey; Christina M Wood; Bruce D Johnson
Journal:  Eur J Heart Fail       Date:  2010-10-29       Impact factor: 15.534

2.  Are transcutaneous oxygen and carbon dioxide determinations of value in pulmonary arterial hypertension?

Authors:  Adriano R Tonelli; Laith Alkukhun; Frank Cikach; Mostafa Ahmed; Raed A Dweik
Journal:  Microcirculation       Date:  2015-05       Impact factor: 2.628

3.  Causes of breathing inefficiency during exercise in heart failure.

Authors:  Paul R Woods; Thomas P Olson; Robert P Frantz; Bruce D Johnson
Journal:  J Card Fail       Date:  2010-06-16       Impact factor: 5.712

4.  Heart rate recovery is an important predictor of outcomes in patients with connective tissue disease-associated pulmonary hypertension.

Authors:  Omar A Minai; Quyen Nguyen; Srinivas Mummadi; Esteban Walker; Kevin McCarthy; Raed A Dweik
Journal:  Pulm Circ       Date:  2015-09       Impact factor: 3.017

5.  Capillary pCO2 helps distinguishing idiopathic pulmonary arterial hypertension from pulmonary hypertension due to heart failure with preserved ejection fraction.

Authors:  Karen M Olsson; Lisa Sommer; Jan Fuge; Tobias Welte; Marius M Hoeper
Journal:  Respir Res       Date:  2015-03-10

Review 6.  Autonomic nervous system involvement in pulmonary arterial hypertension.

Authors:  Mylène Vaillancourt; Pamela Chia; Shervin Sarji; Jason Nguyen; Nir Hoftman; Gregoire Ruffenach; Mansoureh Eghbali; Aman Mahajan; Soban Umar
Journal:  Respir Res       Date:  2017-12-04

7.  Bisoprolol and/or hyperoxic breathing do not reduce hyperventilation in pulmonary arterial hypertension patients.

Authors:  Eva L Peters; Jasmijn S J A van Campen; Herman Groepenhoff; Frances S de Man; Anton Vonk Noordegraaf; Harm J Bogaard
Journal:  Pulm Circ       Date:  2021-12-13       Impact factor: 3.017

8.  A prescribed walking regimen plus arginine supplementation improves function and quality of life for patients with pulmonary arterial hypertension: a pilot study.

Authors:  Mary Beth Brown; Attie Kempf; Catherine M Collins; Gary M Long; Matthew Owens; Shikha Gupta; Yaron Hellman; Vincent Wong; Mark Farber; Tim Lahm
Journal:  Pulm Circ       Date:  2018 Jan-Mar       Impact factor: 3.017

9.  Compromised Cerebrovascular Regulation and Cerebral Oxygenation in Pulmonary Arterial Hypertension.

Authors:  Simon Malenfant; Patrice Brassard; Myriam Paquette; Olivier Le Blanc; Audrey Chouinard; Valérie Nadeau; Philip D Allan; Yu-Chieh Tzeng; Sébastien Simard; Sébastien Bonnet; Steeve Provencher
Journal:  J Am Heart Assoc       Date:  2017-10-12       Impact factor: 5.501

10.  Functional impact of exercise pulmonary hypertension in patients with borderline resting pulmonary arterial pressure.

Authors:  Rudolf K F Oliveira; Mariana Faria-Urbina; Bradley A Maron; Mario Santos; Aaron B Waxman; David M Systrom
Journal:  Pulm Circ       Date:  2017-06-08       Impact factor: 3.017
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.